Trial Details

COMPLETED
Basic Information
Clinical ID c1364
Identifier NCT05157061
Trial Title GOS to Reduce Symptom Severity in IBS
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome|Irritable Bowel Syndrome - Constipation|Irritable Bowel Syndrome - Diarrhoea|Irritable Bowel Syndrome - Mixed
Interventions DIETARY_SUPPLEMENT: Galacto-oligosaccharides (GOS)|DIETARY_SUPPLEMENT: Maltodextrine
Participant Information
Sponsor Clasado
City Leuven
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2021-10-26
Primary Completion Date 2024-08-06
Completion Date 2024-08-06